Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-98,659
Closed -$2.29M 3340
2023
Q4
$2.29M Sell
98,659
-178,567
-64% -$3.59M 0.01% 1423
2023
Q3
$5.47M Sell
277,226
-290,331
-51% -$5.72M 0.01% 851
2023
Q2
$12.9M Buy
567,557
+97,192
+21% +$1.96M 0.03% 542
2023
Q1
$9.24M Buy
470,365
+174,886
+59% +$3.36M 0.03% 618
2022
Q4
$5.08M Buy
+295,479
New +$5.24M 0.02% 850

Other funds holding RXO

John Overdeck's RXO Position: Q1 2024 in Review

John Overdeck sold out of RXO (RXO) in Q1 2024, closing a stake of 98,659 shares — an estimated $2.29M sold.

John Overdeck first reported a position in RXO in Q4 2022 and held it in 5 quarters. The position peaked at $12.9M in Q2 2023. 241 funds tracked by Wall St. Rank hold RXO as of Q1 2024.

  • John Overdeck reported no remaining RXO position as of Q1 2024 after selling out during the quarter.
  • John Overdeck sold 98,659 RXO shares in Q1 2024, an estimated $2.29M.
  • John Overdeck first reported a position in RXO in Q4 2022 and held it in 5 quarters.
  • John Overdeck's RXO position peaked at $12.9M in Q2 2023.
  • 241 funds tracked by Wall St. Rank held RXO as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.